Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice.
Hoogstad-van Evert JS, Cany J, van den Brand D, Oudenampsen M, Brock R, Torensma R, Bekkers RL, Jansen JH, Massuger LF, Dolstra H. Hoogstad-van Evert JS, et al. Among authors: massuger lf. Oncoimmunology. 2017 May 11;6(8):e1320630. doi: 10.1080/2162402X.2017.1320630. eCollection 2017. Oncoimmunology. 2017. PMID: 28919991 Free PMC article.
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer.
Maas RJ, Hoogstad-van Evert JS, Van der Meer JM, Mekers V, Rezaeifard S, Korman AJ, de Jonge PK, Cany J, Woestenenk R, Schaap NP, Massuger LF, Jansen JH, Hobo W, Dolstra H. Maas RJ, et al. Among authors: massuger lf. Oncoimmunology. 2020 Nov 8;9(1):1843247. doi: 10.1080/2162402X.2020.1843247. Oncoimmunology. 2020. PMID: 33224630 Free PMC article.
Harnessing natural killer cells for the treatment of ovarian cancer.
Hoogstad-van Evert JS, Bekkers R, Ottevanger N, Jansen JH, Massuger L, Dolstra H. Hoogstad-van Evert JS, et al. Gynecol Oncol. 2020 Jun;157(3):810-816. doi: 10.1016/j.ygyno.2020.03.020. Epub 2020 Apr 5. Gynecol Oncol. 2020. PMID: 32268953 Free article. Review.
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells.
Van der Meer JMR, Maas RJA, Guldevall K, Klarenaar K, de Jonge PKJD, Evert JSH, van der Waart AB, Cany J, Safrit JT, Lee JH, Wagena E, Friedl P, Önfelt B, Massuger LF, Schaap NPM, Jansen JH, Hobo W, Dolstra H. Van der Meer JMR, et al. Among authors: massuger lf. Cancer Immunol Immunother. 2021 May;70(5):1305-1321. doi: 10.1007/s00262-020-02749-8. Epub 2020 Nov 3. Cancer Immunol Immunother. 2021. PMID: 33140189 Free PMC article.
Peptide-mediated delivery of therapeutic mRNA in ovarian cancer.
van den Brand D, Gorris MAJ, van Asbeck AH, Palmen E, Ebisch I, Dolstra H, Hällbrink M, Massuger LFAG, Brock R. van den Brand D, et al. Eur J Pharm Biopharm. 2019 Aug;141:180-190. doi: 10.1016/j.ejpb.2019.05.014. Epub 2019 May 16. Eur J Pharm Biopharm. 2019. PMID: 31103743
EpCAM-Binding DARPins for Targeted Photodynamic Therapy of Ovarian Cancer.
van den Brand D, van Lith SAM, de Jong JM, Gorris MAJ, Palacio-Castañeda V, Couwenbergh ST, Goldman MRG, Ebisch I, Massuger LF, Leenders WPJ, Brock R, Verdurmen WPR. van den Brand D, et al. Among authors: massuger lf. Cancers (Basel). 2020 Jul 2;12(7):1762. doi: 10.3390/cancers12071762. Cancers (Basel). 2020. PMID: 32630661 Free PMC article.
420 results